Creo Medical Limited carries a market capitalization of 65.46M, placing it among publicly traded companies globally.
| Market Cap | 65.46M |
| Enterprise Value | N/A |
Creo Medical Limited's stock has gained approximately 17.73021% over the past 52 weeks. The 50-day moving average sits at 13.25, while the 200-day moving average is 12.40.
| Beta (5Y) | N/A |
| 52-Week Price Change | 17.73021% |
| 50-Day Moving Average | 13.25 |
| 200-Day Moving Average | 12.40 |
| Average Volume (20 Days) | N/A |
Creo Medical Limited's most recent stock split took place on February 16, 2023 with a 250:259 split ratio.
| Last Split Date | 2/16/2023 |
| Split Ratio | 250:259 |